Szu-Huei Wu

Artificial intelligence approach fighting COVID-19 with repurposing drugs

Yi‐Yu Ke, Tzu-Ting Peng, Teng‐Kuang Yeh et al. · Biomedical Journal · 2020 · 230 citations · Full text

Computing, Infectious Diseases, Pharmacology +9

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2

Hui-Chen Hung, Yi‐Yu Ke, Sheng‐Yu Huang et al. · Antimicrobial Agents and Chemotherapy · 2020 · 111 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification

Yi‐Yu Ke, Vivek Kumar Singh, Mohane Selvaraj Coumar et al. · Scientific Reports · 2015 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Repurposing old drugs as antiviral agents for coronaviruses

Cheng‐Wei Yang, Tzu-Ting Peng, Hsing-Yu Hsu et al. · Biomedical Journal · 2020 · 70 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus

Chi-Chen Yang, Ming‐Han Tsai, Han-Shu Hu et al. · Antiviral Research · 2013 · 32 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +9